These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 2363411
1. Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Byrnes JJ, Moake JL, Klug P, Periman P. Am J Hematol; 1990 Jul; 34(3):169-74. PubMed ID: 2363411 [Abstract] [Full Text] [Related]
2. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy. Byrnes JJ, Moake JL. Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932 [Abstract] [Full Text] [Related]
3. Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura. Moake JL, Byrnes JJ, Troll JH, Rudy CK, Hong SL, Weinstein MJ, Colannino NM. Blood; 1985 May; 65(5):1232-6. PubMed ID: 3873262 [Abstract] [Full Text] [Related]
4. Thrombotic thrombocytopenic purpura: understanding a disease no longer rare. Moake JL, Chow TW. Am J Med Sci; 1998 Aug; 316(2):105-19. PubMed ID: 9704664 [Abstract] [Full Text] [Related]
5. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Moake JL, McPherson PD. Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537 [Abstract] [Full Text] [Related]
11. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura. Tsai HM, Rice L, Sarode R, Chow TW, Moake JL. Ann Intern Med; 2000 May 16; 132(10):794-9. PubMed ID: 10819702 [Abstract] [Full Text] [Related]
12. ADAMTS-13 may not predict disease or outcome in patients with Thrombotic Thrombocytopenic Purpura. Rock G, Clark WF, Anderson D, Benny B, Sutton D, Leblond P, Sternbach M, Sontrop J, Members of the Canadian Apheresis Group. Thromb Res; 2013 Apr 16; 131(4):308-12. PubMed ID: 23411128 [Abstract] [Full Text] [Related]
13. Cryoprecipitate-poor plasma fraction (cryosupernatant) in the treatment of thrombotic thrombocytopenic purpura at onset. A report of four cases. Perotti C, Torretta L, Molinari E, Salvaneschi L. Haematologica; 1996 Apr 16; 81(2):175-7. PubMed ID: 8641652 [Abstract] [Full Text] [Related]
14. Thrombotic thrombocytopenic purpura: evidence that infusion rather than removal of plasma induces remission of the disease. Ruggenenti P, Galbusera M, Cornejo RP, Bellavita P, Remuzzi G. Am J Kidney Dis; 1993 Mar 16; 21(3):314-8. PubMed ID: 8447309 [Abstract] [Full Text] [Related]
16. Treatment of thrombotic thrombocytopenic purpura with the cryosupernatant fraction of plasma: a case report and review of the literature. Ellis J, Theodossiou C, Schwarzenberger P. Am J Med Sci; 1999 Sep 16; 318(3):190-3. PubMed ID: 10487410 [Abstract] [Full Text] [Related]
18. Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission. Di Pasquale I, Budde U, Tona F, Bertomoro A, Lombardi AM, Famoso G, Bertozzi I, Dittmer R, Schneppenheim S, Fabris F. Thromb Res; 2019 Jan 16; 173():42-47. PubMed ID: 30471507 [Abstract] [Full Text] [Related]
19. Enhanced platelet adhesion and aggregation by endothelial cell-derived unusually large multimers of von Willebrand factor. Kumar RA, Moake JL, Nolasco L, Bergeron AL, Sun C, Dong JF, McIntire LV. Biorheology; 2006 Jan 16; 43(5):681-91. PubMed ID: 17047284 [Abstract] [Full Text] [Related]